Wei Sun

Title: Innovations by Wei Sun in Endolysosomal Targeting Conjugates

Introduction

Wei Sun is an accomplished inventor based in College Station, TX (US). He has made significant contributions to the field of drug delivery systems, particularly through his innovative work on endolysosomal targeting conjugates. His research focuses on improving the efficiency of delivering cargo molecules to target cells, such as tumor cells.

Latest Patents

Wei Sun holds a patent for "Endolysosomal targeting conjugates for improved delivery of cargo molecules to the endolysosomal compartment of target cells." This patent describes engineered endolysosomal targeting conjugates designed to deliver cargo molecules, including cytotoxic drugs or imaging labels, with enhanced efficiency to late endosomes and/or lysosomes in target cells. The conjugate comprises a targeting component that binds to a cell surface molecule of a target cell and a cargo component that includes the cargo molecule. The targeting and cargo components can be linked by either covalent or non-covalent bonds, allowing for higher affinity binding in the extracellular space compared to the endolysosomal compartment.

Career Highlights

Wei Sun has worked with prestigious institutions, including the University of Texas System and Texas A&M University System. His work has been instrumental in advancing the understanding and application of targeted drug delivery systems.

Collaborations

Some of his notable coworkers include Elizabeth Sally Ward Ober and Raimund Johannes Ober, who have contributed to his research endeavors.

Conclusion

Wei Sun's innovative work in endolysosomal targeting conjugates represents a significant advancement in drug delivery technology. His contributions are paving the way for more effective treatments in the medical field.